Filing Details

Accession Number:
0001185185-15-002498
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-07 14:59:06
Reporting Period:
2015-10-05
Filing Date:
2015-10-07
Accepted Time:
2015-10-07 14:59:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1530766 Biosig Technologies Inc. BSGM Electromedical & Electrotherapeutic Apparatus (3845) 264333375
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1449534 L Kenneth Londoner C/O Biosig Technologies, Inc.
8441 Wayzata Blvd., Suite 240
Minneapolis MN 55426
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Acquisiton 2015-10-05 6,600 $1.55 752,545 No 4 P Direct
Common Stock, $0.001 Par Value Per Share Acquisiton 2015-10-06 10,494 $1.45 763,039 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share 3,334,974 Indirect By Endicott Management Partners, LLC
Footnotes
  1. This transaction was executed in multiple trades on October 5, 2015 at prices ranging from $1.50 to $1.58. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of securities purchased at each separate price.
  2. This transaction was executed in multiple trades on October 6, 2015 at prices ranging from $1.39 to $1.48. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of securities purchased at each separate price.
  3. Mr. Londoner is deemed the beneficial owner of Endicott Management Partners, LLC.